SARS-CoV-2 RNA in plasma samples of COVID-19 affected individuals: a cross-sectional proof-of-concept study

SARS-CoV-2 RNA in plasma samples of COVID-19 affected individuals: a cross-sectional proof-of-concept study

Abstract Background Recent studies showed that plasma SARS-CoV-2 RNA seems to be associated with worse COVID-19 outcome. However, whether specific population can be at higher risk of viremia are to date unexplored. Methods This cross-sectional proof-of-concept study included 41 SARS-CoV-2-positive a...

Full description

Bibliographic Details
Main Authors: Luna Colagrossi, Maria Antonello, Silvia Renica, Marco Merli, Elisa Matarazzo, Giovanna Travi, Marta Vecchi, Jacopo Colombo, Antonio Muscatello, Giacomo Grasselli, Silvia Nerini Molteni, Vittorio Scaravilli, Emanuele Cattaneo, Diana Fanti, Chiara Vismara, Alessandra Bandera, Andrea Gori, Massimo Puoti, Valeria Cento, Claudia Alteri, Carlo Federico Perno
Format: Article
Language:English
Published: BMC 2021-02-01
Series:BMC Infectious Diseases
Subjects:
Viremia
SARS-CoV-2
COVID-19
ddPCR
Molecular diagnosis
Hematological malignancies
Online Access:https://doi.org/10.1186/s12879-021-05886-2

Internet

https://doi.org/10.1186/s12879-021-05886-2

Similar Items